Nuance Investments LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, Holdings Channel reports. The firm acquired 17,162 shares of the conglomerate’s stock, valued at approximately $3,269,000.
A number of other institutional investors have also made changes to their positions in DHR. Main Street Group LTD acquired a new position in shares of Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher during the second quarter worth approximately $25,000. JPL Wealth Management LLC bought a new position in Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth $26,000. Finally, WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter valued at approximately $26,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Stock Performance
NYSE DHR opened at $202.44 on Tuesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a fifty day moving average price of $193.52 and a 200-day moving average price of $192.67. The firm has a market cap of $142.31 billion, a price-to-earnings ratio of 35.96, a PEG ratio of 2.52 and a beta of 0.78.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on DHR shares. Morgan Stanley lowered their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Jefferies Financial Group reiterated a “buy” rating and issued a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. TD Cowen cut their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.
Read Our Latest Stock Report on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
